Primellose is an excellent choice as superdisintegrant in ODT applications

Similar documents
Content Uniformity of Direct Compression tablets

Re-compaction properties of lactose and microcrystalline cellulose

YOUR ORAL SOLID DOSE. In pursuit of excipient excellence

Formulation and evaluation of oro-dispersible tablets of lafutidine

Short Communication. Formulation of Furosemide Dispersible Tablets for Use in Paediatrics V. V. ABWOVA, P. N. MBEO, L. J. TIROP AND K. A. M.

LubriTose Mannitol Michael Crowley, Director of R&D, Excipients

Int. Res J Pharm. App Sci., 2014; 4(1):47-51 ISSN:

STARCH Proven and Trusted Excipient for Performance and Versatility EXCIPIENTS. Effective and economical disintegrant

Evaluation of different binders for roller compaction R. Wang, W. Liu, T. Durig

Formulation and Evaluation

TECHNICAL INFORMATION RxCIPIENTS FM A versatile excipient for orally disintegrating tablet (ODT) formulations

STARCH Application Data

The influence of lactose particle size on dry powder inhalation performance

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN Research Article

Preformulation Study. CHAPTER 3 Preformulation Study. 3.0 Introduction

The binding performance of DFE Pharma Starch

Available Online through

FORMULATION AND EVALUATION OF PIROXICAM AND CELECOXIB TABLETS EMPLOYING PROSOLVE BY DIRECT COMPRESSION METHOD

The unlocked synergy of DFE Pharma MCC

Formulation and In-vitro Evaluation of Chewable Tablets of Montelukast Sodium

FAST DISPERSING TABLETS REVIEW Chetan V. Suryawanshi*, N. A. Gujrathi, B. R. Rane

Development and Evaluation of Orally Disintegrating Tablet by Direct Compression Method

Technical brochure StarLac

Research Paper The Effect of Different Superdisintegrants and their Concentrations on the Dissolution of Topiramate Immediate Release Tablets

EFFECT OF SUPERDISINTEGRANTS ON RELEASE OF DOMPERIDONE FROM FAST DISSOLVING TABLETS

Asian Journal of Pharmacy and Life Science ISSN Vol. 2 (2), July-Sept,2012

Formulation and Evaluation of Etoricoxib Oro Dispersable Tablets by Direct Compression Method

Mathivanan. N et al, JGTPS, 2015, Vol. 6(2):

Design and development of fast Melting Tablets of Terbutaline Sulphate

Formulation and Evaluation of Immediate Release Tablets of Allopurinol

B. Jayakar et. al. FORMULATION AND EVALUATION OF ORODISPERSIBLE TABLET OF CELECOXIB R. Margret Chandira, Shyam Sharma, Debjit Bhowmik, B.

Formulation and evaluation of intraorally fast dissolving tablet of olmesartan medoxomil

Application of Starches, Modified Starches and Starch Derivatives in Pharmaceutical Products

Scholars Research Library. Formulation and evaluation of rizatriptan benzoate orodispersible tablets

Lactose Free, Direct Compression Formulation Used to Produce Loratadine (10 mg) Tablets

Karnataka Department of Pharmaceutical Technology, H.K.E. Society s College of Pharmacy, Gulbarga, Karnataka ABSTRACT KEYWORDS:

EXPANDING WHAT S POSSIBLE WITH THE RIGHT PARTNER. Life-saving pharmaceuticals start with high-quality ingredients

ORAL DOSAGE OVERVIEW

Effect of superdisintegrants and their mode of incorporation on disintegration time and release profile of carbamazepine from immediate release tablet

Studies of Rapidly Disintegrating Tablets in the Oral Cavity Using Co-ground Mixtures of Mannitol with Crospovidone

Coprocessed Excipients for Orally Disintegrating Dosage Form

Journal of Chemical and Pharmaceutical Research

FORMULATION AND EVALUATION OF BISOPROLOL FUMARATE FAST DISSOLVING TABLET BY DIRECT COMPRESSION TECHNIQUES

Formulation and Evaluation of Oral disintegrated tablets of Alfuzosin Hydrochloride using superdisintegrants

FORMULATIO A D EVALUATIO OF ORO DISPERSIBLE TABLETS OF CLO AZEPAM BY DIRECT COMPRESSIO METHOD

Effect of Common Excipients on the Oral Drug Absorption of Biopharmaceutics Classification System Class 3 Drugs

Pharmacologyonline 2: (2011) ewsletter Mehul et al. FORMULATIO A D EVALUATIO OF ORODISPERSIBLE TABLETS OF PHE IRAMI E MALEATE

FORMULATION DEVELOPMENT AND IN-VITRO EVALUATION OF ORALLY DISINTEGRATING TABLETS OF AMLODIPINE BESYLATE

Int. Res J Pharm. App Sci., 2012; 2(5): ISSN:

FORMULATION DEVELOPMENT AND EVALUATION OF MOUTH DISSOLVING TABLET OF TRAMADOL HYDROCHLORIDE

DESIGN AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF FLURBIPROFEN

FORMULATION DEVELOPMENT AND IN-VITRO CHARACTERIZATION OF BILAYER TABLETS OF AMOXICILLIN AND FAMOTIDINE

Technical brochure CombiLac

Formulation Development and Evaluation of Ondansetron Hcl Fast Dispersing Tablets for Treatment of Chemotherapy

STUDY ON THE INFLUENCE OF GELUCIRE SORT ON THE RELEASE OF ACETAMINOPHEN FROM ORALLY DISINTEGRATING TABLETS

Ingredients adapted to a fit for use model. APIs allowed the fit for use strategy to work. There has been a shift to designed for purpose

International Journal of Pharma and Bio Sciences NOVEL CO-PROCESSED SUPERDISINTEGRANTS IN THE DESIGN OF FAST DISSOLVING TABLETS

Formulation and Evaluation of Amlodipine besylate orally disintegrating tablet

Design and evaluation of immediate release tablets of divalproex sodium

Critical material properties for the design of robust drug products : excipient functionality related characteristics

Formulation and evaluation of immediate release salbutamol sulphate

VIVAPHARM PVP/VA. Copovidone, Ph.Eur. USP/NF, JPE, E. The Ultimate Tablet Binder for All Processing Technologies

FORMULATION AND EVALUATION OF CEFIXIME TRIHYDRATE ORAL DISINTEGRATING AGENTS

Available online Research Article

Formulation Development, Evaluation and Comparative Study of Effects of Super Disintegrants in Cefixime Oral Disintegrating Tablets

Optimization of valsartan tablet formulation by 2 3 factorial design

(51) Int Cl.: A61K 9/20 ( ) A61K 31/41 ( )

International Journal of Pharma and Bio Sciences FORMULATION AND EVALUATION OF TASTE MASKED DISPERSIBLE TABLETS OF ZIDOVUDINE YASH PAUL ABSTRACT

PREPARATION AND EVALUATION OF STARCH - PEG 1500 CO-PROCESSED EXCIPIENT AS A NEW DIRECTLY COMPRESSIBLE VEHICLE IN TABLET FORMULATIONS

ISSN: CODEN Code: PIHNBQ ZDB-Number: IC Journal No: Vol. 2 No Online Available at

Pavan K et al IJARPB: 2013, 3(2), ISSN: Available online on Research Article

Formulation and development of orodispersible tablet of Memantine HCl by sublimation approach

Formulation and evaluation of fast dissolving tablet of aceclofenac

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE

7. SUMMARY, CONCLUSION AND RECOMMENDATIONS

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN Research Article

Formulation and In-vitro Evaluation of Sumatriptan succinate Bilayer Tablets

INTERNATIONAL JOURNAL OF PHARMACY & LIFE SCIENCES

Formulation and Evaluation of Rosuvastatin Immediate Release Tablets 10 Mg

OPTIMIZATION OF CONTROLLED RELEASE GASTRORETENTIVE BUOYANT TABLET WITH XANTHAN GUM AND POLYOX WSR 1105

Research Paper Preparation and Evaluation of Rapidly Disintegrating Glimepiride Tablets

PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES

CHAPTER 5: FORMULATION OF SOLID DOSAGE FORM (TABLET & CAPSULES) INTRODUCTION

Available online through ISSN

Formulation, Optimization and Evaluation of Mouth Dissolving Tablet of Zidovudine

M.Vijaya Laxmi et al., Asian Journal of Pharmaceutical Technology & Innovation, 03 (10); 2015; Research Article

Adimoolam Senthil et al. IRJP 2 (1)

Research Article. Formulation and in-vitro evaluation of levocetirizine dihydrochloride orodispersible tablets

FORMULATION AND EVALUATION OF AMISULPRIDE ORODISPERSIBLE TABLET

The purpose of this research work was to develop a stable formulation of Antihypertensive drugs of the

Research Article. Formulation and Evaluation of Oral Dispersible Tablets of Zidovudine with different Superdisintegrants.

TEPZZ Z697_5A_T EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (51) Int Cl.: A61K 9/20 ( ) A61K 31/135 (2006.

INTERNATIONAL JOURNAL OF INSTITUTIONAL PHARMACY AND LIFE SCIENCES

Received on: Accepted on:

Formulation and Optimization of Lamotrigin Fast Dissolving Tablet

Formulation and evaluation of lansoprazole orodispersable tablets using novel excipients

Influence of blender type on the performance of ternary dry powder inhaler formulations

OCE TABLETING DIRECT COMPRESSION CO-PROCESSED LACTOSE. Technical brochure MicroceLac 100

Narrowing the gap between clinical capsule formulations and commercial film-coated tablets

Transcription:

Primellose is an excellent choice as superdisintegrant in ODT applications MCC Starch Lactose Inhalation Superdisintegrants

Summary In orally disintegrating tablets, the excipients of choice in direct compression are mannitol as filler binder and crospovidone as the superdisintegrant. An alternative superdisintegrant, Primellose, is produced from natural resources in contrast to some other superdisintegrants. Here we show that Primellose (croscarmellose sodium) gives fast disintegration of tablets. Therefore, we conclude that Primellose is very effective and an excellent choice as superdisintegrant in ODT applications. 1 Introduction Orally disintegrating tablets are tablets that should do what is in their name: disintegrate in the oral cavity. To do so, the tablet should disintegrate quickly, with a limited supply of water, and mask the taste of the dispersing drug. Fast disintegration is described by FDA to be faster than thirty seconds, (1) but in practice it should be even faster. Several strategies exist in order to prepare ODT tablets. For practical and economic reasons, an interesting method for preparation of ODT tablets is by direct compression (DC). (2) A number of combination products have been developed such as Ludiflash and Parteck-ODT. The majority of DC tablets for ODT are formulated with mannitol as filler-binder and crospovidone as disintegrant. (3) These types of tablets have been reported to disintegrate between 10-60 seconds. (4) Figure 1. Chemical structure of Primellose Here we will show that (placebo) tablets formulated with Primellose as the superdisintegrant gave tablet disintegration comparable to that of DC tablets designed for ODT applications. For economic reasons, croscarmellose sodium is the preferred superdisintegrant. And because it is based on cellulose, it is produced from natural and renewable resources, in contrast to for instance crospovidone which is completely synthetic in nature. 2 Methods and Materials Figure 2. SEM picture of Primellose Placebo tablets were prepared with croscarmellose sodium (Primellose, DFE Pharma), and with lactose (SuperTab 30GR, DFE Pharma) or mannitol (Pearlitol SD, Roquette) according to Table 1. SuperTab 30 GR is agglomerated α-lactose monohydrate. For each formulation (500 gr), SuperTab 30 GR or Primellose is an excellent choice as superdisintegrant in ODT applications 3

mannitol and Primellose were blended in a Turbula blender for eight minutes at a rate of 90 rpm. Then magnesium stearate (Sigma) was added and blending was commenced for another two minutes. The blend was fed to a RoTab tableting press with a die filling of 250 mg and a tableting force of 4, 6, 8, and 10 kn. Table 1. Placebo formulations, amounts in milligrams/tablet Supertab 30GR Mannitol Primellose Mag. St. 1 248.75 1.25 2 243.75 5 (2%) 1.25 3 238.75 10 (4%) 1.25 4 233.75 15 (6%) 1.25 5 242.5 6.25 (2.5%) 1.25 6 236.25 12.5 (5%) 1.25 Tablet disintegration was measured on the Erweka Disintegration tester model ZT122 in water at 37 C. Tablet friability and tablet hardness were tested according USP methods. 3 Results and Discussion Tablet strength was determined, and as expected the strength increased with increasing tableting force and is dependent on the major excipient (Supertab 30GR and mannitol). The tablet hardness was not or only slightly dependent on the amount of superdisintegrant. Figure 3. Relation of tablet hardness vs. compaction force Friability of the tablets was determined and found to be dependent on the compaction force. Tablets pressed at 4 kn where the most friable with weight losses in the order of 1%. At higher compaction forces, the weight losses were in general in the order of <0.2%. The disintegration time of the placebo tablets with 30 GR and Primellose are depicted in Table 3. Table 2. Disintegration time of Supertab 30GR tablets with Primellose as disintegrant (friability and tablet hardness in brackets) Compaction Primellose concentration force (kn) 0% 2% 4% 6% 4 332 s (1.1%; 16.5N) 42 s (1.1%; 16.8N) 44 s (1.4%; 14.9N) 42 s (2.5%; 12.2N) 6 410 s (0.5%; 39.4N) 56 s (0.4%; 38.4N) 47 s (0.4%; 36.5N) 49 s (0.4%; 32.5N) 8 385 s (0.3%; 55.5N) 38 s (0.3%; 54.3N) 45 s (0.2%; 53.1N) 46 s (0.2%; 51.3N) 10 427 s (0.2%; 73.4N) 28 s (0.1%; 75.3N) 47 s (0.1%; 73.0N) 47 s (0.1%; 70.6N) 4 Primellose is an excellent choice as superdisintegrant in ODT applications

It can be concluded that addition of superdisintegrant has a profound effect on the disintegration time. Secondly, it can be concluded that the disintegration time is hardly dependent on the tablets hardness. Disintegration times of direct compression based tablets have been reported to be in the order of 20-60 seconds, in accordance with these lactose based tablets. The most widely used excipient for ODT applications is mannitol. Therefore, tablets based on mannitol were prepared as well. Disintegration of those tablets is depicted in Figure 4 and it can be observed the disintegration time varies from 10-20 s and that there is a small dependence with the compaction force. Furthermore, decreasing the amount of Primellose did not have a very large effect on the disintegration time, which was observed for the lactose based tablets as well. Figure 4. Tablet disintegration time of mannitol based tablets with 5% and 2.5% primellose The measured disintegration time is well in line or even better than reported tablet disintegration times of ODT formulation. 4 Conclusion We conclude that Primellose is an excellent superdisintegrant which gives tablets that disintegrate with a similar rate as is reported for DC based ODT tablets. Primellose is already very effective at relative low concentrations. References 1. Guidance for Industry Orally Disintegrating Tablets (FDA, Rockville, MD), www.fda.gov/cder/guidance/index.htm, December 2008 2. WR Pfister, TK Ghosk, Pharm. Tech. 2005, 29(10), 136-150. 3. Y Zhang, A Wrzesinski, M Moses, H Betrand, Pharm. Tech., 2010, 34(7), 54-61. 4. JJ Hirani, DA Rathod, KR Vadalia, Tropical J. Pharm. Res., 2009, 8(2), 161-172. Primellose is an excellent choice as superdisintegrant in ODT applications 5

DFE Pharma (#code/month year) 6 Primellose is an excellent choice as superdisintegrant in ODT applications